ヒアルロン酸ベース皮膚充填剤の市場規模、シェア、動向分析レポート：用途別、製品別、地域別、セグメント予測、2024年～2030年

ヒアルロン酸ベース皮膚充填剤市場の成長と動向：

Grand View Research, Incの最新レポートによると、ヒアルロン酸ベース皮膚充填剤の世界市場規模は2030年までに82億4,000万米ドルに達すると予測され、2024年から2030年までのCAGRは10.5％で成長すると予測されています。

低侵襲処置に対する需要の増加、老人人口の増加、若い肌に対する意識と関心の高まり、技術の進歩が市場成長を促進する主な要因です。

世界的に高齢化人口が増加しています。2030年までに世界の6人に1人が60歳以上になり、高齢者人口は11億人から14億人に増加します。米国では、2060年までに人口の4分の1が65歳以上になると推定されています。現在、60歳以上の世界人口の3分の2が中所得国であり、中所得国が大きな変化を目の当たりにしています。

しかし、市場コストの高さが市場機会を抑制しています。HAベースの皮膚充填剤は1mlのシリンジで入手でき、1シリンジあたり600-1,000米ドルです。ほとんどの場合、最低2シリンジの投与が必要であり、治療費は1600-2,000米ドルとかなり高額になります。製品のコストが高いため、低中所得国の人々には難しいです。

ヒアルロン酸ベース皮膚充填剤市場レポート・ハイライト

• 単相製品セグメントは、2023年に54.76%の最大収益シェアで市場を占めました。
• 用途別では、シワ取り分野が2023年に29.53%の最大売上シェアで市場をリードしました。これは、美容整形への支出が増加していることと、HAベースのフィラーを使用したしわ取り技術の登場によるものです。シワ取りは最も一般的な皮膚トラブルであり、その結果、このセグメントの需要が高まっています。
• 北米が2023年に最大の売上高シェアで市場を独占しました。例えば、2021年9月に発表されたカナダ統計局の人口統計によると、カナダの60歳以上の総人口は96,88,677人です。
• アジア太平洋市場は、日本、中国、韓国のような国の急速な経済成長と地域のヘルスケアインフラの改善により、予測期間中に最も速いCAGRで成長すると予想されます。
• Allergan（AbbVie）は世界市場をリードする主要企業のひとつです。これは、同社によるHAベースの皮膚充填剤Juvedermの長期にわたる市場での存在感と、新製品が投入されているにもかかわらず製品の性能が高いことに起因しています。同社は、HAベースの皮膚充填剤の強力な製品ポートフォリオを有しており、革新的な製品を市場に投入することに注力しています。

目次

第1章 ヒアルロン酸ベース皮膚充填剤市場：調査手法と範囲

第2章 ヒアルロン酸ベース皮膚充填剤市場：エグゼクティブサマリー

• 市場見通し
• セグメント展望
• 競合考察

第3章 ヒアルロン酸ベース皮膚充填剤市場：変数、動向、範囲

• 市場系統の見通し
• 市場力学
• ビジネス環境分析ツール
• 定性分析： COVID-19がヒアルロン酸ベース皮膚充填剤市場に与える影響

第4章 ヒアルロン酸ベース皮膚充填剤市場：製品の推定・動向分析

• ヒアルロン酸ベース皮膚充填剤市場：製品のダッシュボード
• ヒアルロン酸ベース皮膚充填剤市場：製品の変動分析
• ヒアルロン酸ベース皮膚充填剤市場規模と予測および動向分析、製品別、2018～2030年
• 単相製品
• デュプレックス製品

第5章 ヒアルロン酸ベース皮膚充填剤市場：用途の推定・動向分析

• ヒアルロン酸ベース皮膚充填剤市場：用途のダッシュボード
• ヒアルロン酸ベース皮膚充填剤市場：用途の変動分析
• ヒアルロン酸ベース皮膚充填剤市場規模と予測および動向分析、用途別、2018～2030年
• しわ除去
• 口唇拡大
• 鼻形成術
• その他

第6章 ヒアルロン酸ベース皮膚充填剤市場：地域の推定・動向分析

• ヒアルロン酸ベース皮膚充填剤市場：地域ダッシュボード
• 市場規模と予測動向分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • Key company market share analysis, 2023
  • Allergan;Galderma Laboratories
  • Merz Pharmaceuticals
  • Genzyme Corporation
  • Anika Therapeutics Inc.
  • LG Life Sciences
  • LTD（LG Chem）
  • Bio plus Co. Ltd.
  • Sculpt Luxury
  • Dermal Fillers Ltd.
  • Bioxis Pharmaceutical
  • Sinclair Pharma;Laboratories
  • Vivacy;Bohus Biotech AB

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 QFD modelling for market share assessment
• Fig. 6 Market formulation & validation
• Fig. 7 Market outlook
• Fig. 8 Hyaluronic acid-based dermal fillers market segmentation
• Fig. 9 Penetration & growth prospect mapping
• Fig. 10 Market trends & outlook
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Hyaluronic acid-based dermal fillers product market share analysis, 2023 & 2030
• Fig. 14 Hyaluronic acid-based dermal fillers product market: Segment dashboard
• Fig. 15 Single-phase product market estimates and forecast, 2018 - 2030
• Fig. 16 Duplex product market estimates and forecast, 2018 - 2030
• Fig. 17 Hyaluronic acid-based dermal fillers application market share analysis, 2023 & 2030
• Fig. 18 Hyaluronic acid-based dermal fillers application market: Segment dashboard
• Fig. 19 Wrinkle removal market estimates and forecasts, 2018 - 2030
• Fig. 20 Lip augmentation market estimates and forecasts,2018 - 2030
• Fig. 21 Rhinoplasty market estimates and forecasts, 2018 - 2030
• Fig. 22 Others market estimates and forecasts, 2018 - 2030
• Fig. 23 Hyaluronic acid-based dermal fillers regional market share analysis, 2023 & 2030
• Fig. 24 Hyaluronic acid-based dermal fillers regional market: Segment dashboard
• Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Company market position analysis.

Hyaluronic Acid-based Dermal Fillers Market Growth & Trends:

The global hyaluronic acid-based dermal fillers market size is anticipated to reach at USD 8.24 billion by 2030 and is projected to grow at a CAGR of 10.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. The increasing demand for minimally invasive procedures, growing geriatric population, increasing awareness & concern for younger skin and advancement in technology are key factors driving the market growth.

The global ageing population is increasing. By 2030, 1 in 6 persons globally will be above 60 years old or over with total elder population growing from one 1 to 1.4 billion. In the U.S., it is estimated that one fourth of the people will be above 65 by 2060. Currently the middle-income countries are witnessing huge change with two-thirds of global population over 60 years would be from middle-income countries.

However, the higher cost of market is restraining the market opportunities. The HA-based dermal fillers are available in syringes of 1ml costing USD 600-1000 per syringe. Most of the times a dosage of minimum 2 syringes is required, taking the cost of treatment to USD 1600-2000 which is quite high. The high cost of products makes it difficult for the population of low- medium-income countries.

Hyaluronic Acid-based Dermal Fillers Market Report Highlights:

• The single-phase products segment held the market with the largest revenue share of 54.76% in 2023, owing to the benefits like better effectiveness & offered by these products
• Based on application, the wrinkle removal segment led the market with the largest revenue share of 29.53% in 2023. This can be attributed to the increasing spending on cosmetic procedures and the advent of technology for Wrinkle Removal suing HA-based fillers. Wrinkle Removal is the most common skin problems, resulting higher demand for the segment
• North America dominated the market with the largest revenue share of in 2023. This can be attributed to favorable government policies, a rise in the number of plastic surgery procedures and an growing ageing population in the region For instance, as per the Statistics Canada's population statistics published in September 2021, the total population above 60 years of age in Canada is 96, 88,677
• The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the rapid economic growth in nation like Japan, China & South Korea and improvement in healthcare infrastructure in the region
• Allergan (AbbVie), is a one of the major global market leaders. This can be attributed to market presence of Juvederm, a HA based dermal filler by the company for long time and better performance of product despite new products being introduced. The company's has powerful product portfolio of HA based dermal fillers & focuses on introducing innovative products into in market

Table of Contents

Chapter 1 Hyaluronic Acid-based Dermal Fillers Market: Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Product
  • 1.1.2 Application
  • 1.1.3 Regional Scope
  • 1.1.4 Estimates and Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Objectives
  • 1.9.1 Objective 1
  • 1.9.2 Objective 2
  • 1.9.3 Objective 3

Chapter 2 Hyaluronic Acid-based Dermal Fillers Market: Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
  • 2.2.1 Product
  • 2.2.2 Application
  • 2.2.3 Region
• 2.3 Competitive Insights

Chapter 3 Hyaluronic Acid-based Dermal Fillers Market: Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Growing Aging Population
    • 3.2.1.2 Increasing Awareness and Acceptance of Aesthetic Treatments
    • 3.2.1.3 Technological Advancements
  • 3.2.2 Market Restraint Analysis
  • 3.2.3 Regulatory Contraints
  • 3.2.4 High Cost of Procedures
• 3.3 Business Environment Analysis Tools
  • 3.3.1 Porter's five forces analysis
    • 3.3.1.1 Bargaining power of buyers: Low
    • 3.3.1.2 Bargaining power of suppliers: Moderate
    • 3.3.1.3 Competitive Rivalry: High
    • 3.3.1.4 Threat of new entrants: Moderate
    • 3.3.1.5 Threat of substitutes: Low
  • 3.3.2 SWOT Analysis, by PESTEL
    • 3.3.2.1 Political & legal
    • 3.3.2.2 Economic
    • 3.3.2.3 Technological
• 3.4 Qualitative Analysis: Impact of COVID-19 on Hyaluronic Acid-based Dermal Fillers Market Market

Chapter 4. Hyaluronic Acid-based Dermal Fillers Market: Product Estimates & Trend Analysis

• 4.1. Hyaluronic Acid-based Dermal Fillers Market: Product Dashboard
• 4.2. Hyaluronic Acid-based Dermal Fillers Market: Product Movement Analysis
• 4.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Single-Phase Product
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Duplex Product
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid-based Dermal Fillers Market: Application Estimates & Trend Analysis

• 5.1. Hyaluronic Acid-based Dermal Fillers Market: Application Dashboard
• 5.2. Hyaluronic Acid-based Dermal Fillers Market: Application Movement Analysis
• 5.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Wrinkle Removal
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Lip Augmentation
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Rhinoplasty
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis by Country, Type & Therapy

• 6.1. Hyaluronic Acid-based Dermal Fillers Market: Regional Dashboard
• 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.9. Denmark
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Regulatory framework/ reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3. Japan
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.7. South Korea
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.3. Mexico
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.4. Argentina
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.3. South Africa
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key company market share analysis, 2023
  • 7.3.2. Allergan; Galderma Laboratories
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Type benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Merz Pharmaceuticals
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Type benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Genzyme Corporation
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Type benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Anika Therapeutics Inc.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Type benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. LG Life Sciences
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Type benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. LTD (LG Chem)
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Type benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Bio plus Co. Ltd.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Type benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Sculpt Luxury
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Type benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Dermal Fillers Ltd.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Type benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Bioxis Pharmaceutical
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Type benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Sinclair Pharma; Laboratories
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Type benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Vivacy; Bohus Biotech AB
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Type benchmarking
    • 7.3.13.4. Strategic initiatives